BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2983560)

  • 1. Clinicopathologic responses in cats with feline leukemia virus-associated leukemia-lymphoma treated with staphylococcal protein A.
    Engelman RW; Tyler RD; Trang LQ; Liu WT; Good RA; Day NK
    Am J Pathol; 1985 Mar; 118(3):367-78. PubMed ID: 2983560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clearance of retroviremia and regression of malignancy in cats with leukemia-lymphoma during treatment with staphylococcal protein A.
    Engelman RW; Good RA; Day NK
    Cancer Detect Prev; 1987; 10(5-6):435-44. PubMed ID: 3032440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of protein A administered intravenously to pet cats with leukemia or lymphosarcoma.
    Harper HD; Sjöquist J; Hardy WD; Jones FR
    Cancer; 1985 May; 55(9):1863-7. PubMed ID: 2983866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appearance of cytotoxic antibody to viral gp70 on feline lymphoma cells (FL-74) in cats during ex vivo immunoadsorption therapy: quantitation, characterization, and association with remission of disease and disappearance of viremia.
    Liu WT; Engelman RW; Trang LQ; Hau K; Good RA; Day NK
    Proc Natl Acad Sci U S A; 1984 Jun; 81(11):3516-20. PubMed ID: 6328520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological effects of staphylococcal protein A immunotherapy in cats with induced feline leukemia virus infection.
    Lafrado LJ; Mathes LE; Zack PM; Olsen RG
    Am J Vet Res; 1990 Mar; 51(3):482-6. PubMed ID: 1690524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphosarcoma and persistent feline leukemia virus infection of pet cats: a system to study responses during extracorporeal treatments.
    Jones FR; Grant CK; Snyder HW
    J Biol Response Mod; 1984; 3(3):286-92. PubMed ID: 6086847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remission of lymphoma leukemia in cats following ex vivo immunosorption therapy using Staphylococcus protein A.
    Day NK; Engelman RW; Liu WT; Trang L; Good RA
    J Biol Response Mod; 1984; 3(3):278-85. PubMed ID: 6086846
    [No Abstract]   [Full Text] [Related]  

  • 8. Remission of leukemia and loss of feline leukemia virus in cats injected with Staphylococcus protein A: association with increased circulating interferon and complement-dependent cytotoxic antibody.
    Liu WT; Good RA; Trang LQ; Engelman RW; Day NK
    Proc Natl Acad Sci U S A; 1984 Oct; 81(20):6471-5. PubMed ID: 6208551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy for feline leukemia, using staphylococcal protein A or heterologous interferons: immunopharmacologic actions and potential use.
    Weiss RC
    J Am Vet Med Assoc; 1988 Mar; 192(5):681-4. PubMed ID: 2453494
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical aspects of infection with feline leukemia virus in cats].
    Theilen GH
    Tierarztl Prax; 1984; 12(4):511-22. PubMed ID: 6098972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing manifestations of a chronic feline haematopoietic proliferative disease during immunotherapy with staphylococcal protein A.
    Engelman RW; Tyler RD; Mosier DA; Good RA; Day NK
    J Comp Pathol; 1986 Mar; 96(2):177-88. PubMed ID: 3009564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remission of FeLV-associated lymphosarcoma and persistent viral infection after extracorporeal immunoadsorption of plasma using staphylococcal protein A columns: details of immune response.
    Snyder HW; Reed DE; Jones FR
    Semin Hematol; 1989 Apr; 26(2 Suppl 1):25-30. PubMed ID: 2543084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and significance of feline leukemia virus infection in necropsied cats.
    Reinacher M; Theilen G
    Am J Vet Res; 1987 Jun; 48(6):939-45. PubMed ID: 3037951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematology and serum biochemistry of feline immunodeficiency virus-infected and feline leukemia virus-infected cats.
    Gleich S; Hartmann K
    J Vet Intern Med; 2009; 23(3):552-8. PubMed ID: 19645840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and sequelae of feline leukemia virus infection in laboratory cats.
    Ladiges WC; DiGiacomo RF; Wardrop KJ; Hardy WD
    J Am Vet Med Assoc; 1981 Dec; 179(11):1206-7. PubMed ID: 6276347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of persistent viraemia and latent feline leukaemia virus infection in cats with lymphoma.
    Stützer B; Simon K; Lutz H; Majzoub M; Hermanns W; Hirschberger J; Sauter-Louis C; Hartmann K
    J Feline Med Surg; 2011 Feb; 13(2):81-7. PubMed ID: 21131219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematologic abnormalities preceding apparent recovery from feline leukemia virus infection.
    Lester SJ; Searcy GP
    J Am Vet Med Assoc; 1981 Mar; 178(5):471-4. PubMed ID: 6263848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of feline leukemia virus infection on neutrophil chemotaxis in vitro.
    Kiehl AR; Fettman MJ; Quackenbush SL; Hoover EA
    Am J Vet Res; 1987 Jan; 48(1):76-80. PubMed ID: 3030165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of thymectomy on the susceptibility of cats to feline leukemia virus and lymphosarcoma.
    Hoover EA; Krakowka S; Cockerell GL; Mathes LE; Olsen RG
    Am J Vet Res; 1978 Jun; 39(6):993-5. PubMed ID: 208436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No benefit of therapeutic vaccination in clinically healthy cats persistently infected with feline leukemia virus.
    Helfer-Hungerbuehler AK; Spiri AM; Riond B; Grest P; Boretti FS; Hofmann-Lehmann R
    Vaccine; 2015 Mar; 33(13):1578-85. PubMed ID: 25698488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.